Lonza | LONN - Ordinary Share Capital


Lonza reported CHF68.64M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Akzo Nobel EUR 171.31M 200K Mar/2026
Alcon AG USD 487.4M 0 Mar/2026
Almirall EUR 214.79M 0 Dec/2025
AstraZeneca USD 1.55B 73K Mar/2026
BASF EUR 892.52M 249.48M Sep/2025
Bayer EUR 982.42M 0 Dec/2025
Beiersdorf EUR 218.92M 1.29M Dec/2025
Covestro EUR 207.64M 18.9M Dec/2025
Demant DKK 210.9M 5.18M Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
Geberit CHF 32.97M 11.38K Dec/2025
Genmab DKK 61.62M 52K Dec/2025
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GN Store Nord DKK 145.61M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Johnson Matthey GBP 168.06M 0 Jun/2026
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.91B 60K Mar/2026
Philips EUR 952.02M 729K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Sika AG CHF 160.44M 5.27K Dec/2025
Smith & Nephew USD 875.96M 1.61M Dec/2025
Solvay EUR 104.48M 18K Mar/2026
UCB EUR 190.36M 365.15K Dec/2025